A detailed history of Qtron Investments LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Qtron Investments LLC holds 7,752 shares of CTLT stock, worth $466,902. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,752
Holding current value
$466,902
% of portfolio
0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$53.58 - $57.02 $415,352 - $442,019
7,752 New
7,752 $435,000
Q4 2021

Feb 16, 2022

SELL
$119.57 - $139.07 $251,933 - $293,020
-2,107 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$100.34 - $115.69 $385,104 - $444,018
-3,838 Reduced 64.56%
2,107 $228,000
Q1 2021

May 13, 2021

BUY
$101.51 - $125.27 $152,772 - $188,531
1,505 Added 33.9%
5,945 $626,000
Q4 2020

Feb 12, 2021

BUY
$85.88 - $105.36 $93,695 - $114,947
1,091 Added 32.58%
4,440 $462,000
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $243,606 - $309,782
3,349 New
3,349 $287,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.